@article{63efe1125efc415f932b1ae3026c92c2,
title = "Standard chemoradiation in combination with VEGF targeted therapy for glioblastoma results in progressive gray and white matter volume loss",
keywords = "brain atrophy, chemoradiation, glioblastoma, neuroimaging, neurotoxicity",
author = "Prust, {Morgan L.} and Kourosh Jafari-Khouzani and Jayashree Kalpathy-Cramer and Pavlina Polaskova and Batchelor, {Tracy T.} and Gerstner, {Elizabeth R.} and Jorg Dietrich",
note = "Funding Information: This work was conducted with support from the National Cancer Institute and NIH, R01CA129371 and K24CA125440A (T.T.B.), the American Brain Foundation (J.D.), the American Cancer Society (J.D.), internal funds from the Department of Radiology at the Massachusetts General Hospital (E.R.G., K.J-K, J.K-C, and P.P.), and philanthropic support from the Amy Gallagher Foundation (to J.D.).",
year = "2018",
month = jan,
day = "22",
doi = "10.1093/neuonc/nox217",
language = "English (US)",
volume = "20",
pages = "289--291",
journal = "Neuro-Oncology",
issn = "1522-8517",
publisher = "Oxford University Press",
number = "2",
}